AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |
Back to Blog
Agena covid testing8/15/2023 ![]() Previously, Roopom led teams at McKinsey, Leerink and Goldman Sachs where he completed 80+ healthcare transactions raising over $10Bn in capital financings, 30+ IPOs, and 20+ M&A transactions. Most recently, he was President and CEO of RainDance Technologies (acquired by BioRad Labs) and led the company to become a pioneer in Liquid Biopsy for detecting cancer from a blood test. He has broad experience with startups to global Fortune 500 companies advising on corporate strategy, portfolio design, product development and commercialization, financing, partnerships and acquisitions. Roopom is a life science business leader with 20 years’ experience covering strategy, financial advisory, operational and scientific roles. van ‘t Veer with a European Inventor Award.ĬHIEF STRATEGY OFFICER AND HEAD OF BUSINESS DEVELOPMENT In 2015, the European Patent Office (EPO) recognized MammaPrint’s impact on breast cancer diagnostics by honoring Dr. She was awarded a 2014 European Union Prize for Women Innovators that acknowledges the ways MammaPrint has helped transform breast cancer care. ![]() She is also the former head of the NKI’s DNA-diagnostic laboratory. ![]() van ‘t Veer was appointed Professor of Laboratory Medicine and Director of Applied Genomics at the University of California San Francisco. After patenting their innovation, she and research partner René Bernards founded Agendia and launched the MammaPrint test. They established that a specific DNA signature made up of 70 genes distinguished whether breast cancer tumors had a low or high risk of recurrence. van ‘t Veer is best known for work stemming from a discovery she and her team made at the Netherlands Cancer Institute (NKI). She has a 20-year track record in molecular oncology research, which includes more than 230 scientific publications and prestigious awards for her contributions to breast cancer care.ĭr. As one of the world’s leading innovators in cancer diagnostics, she is widely recognized as a pioneer in the field of personalized medicine, also known as precision medicine. Laura van ‘t Veer, PhD, is co‑founder of Agendia and serves as its Chief Research Officer. CHIEF RESEARCH OFFICER (CRO) AND CO‑FOUNDER
0 Comments
Read More
Leave a Reply. |